Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 61-70 of 146 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?Wabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Hall, C.; Spargo, L.; Metcalf, R.; Proudman, S.; Wiese, M.
2012Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysisGraf, S.; Lester, S.; Nossent, J.; Hill, C.; Proudman, S.; Lee, A.; Rischmueller, M.
2016The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyThakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Sahhar, J.; G Walker, J.; Roddy, J.; Lester, S.; Rischmueller, M.; Zochling, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2016Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remissionWechalekar, M.; Lester, S.; Hill, C.; Lee, A.; Rischmueller, M.; Smith, M.; Walker, J.; Proudman, S.
2017Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosisMorrisroe, K.; Stevens, W.; Huq, M.; Sahhar, J.; Ngian, G.; Zochling, J.; Roddy, J.; Proudman, S.; Nikpour, M.; Rischmueller, M.; ustralian Scleroderma Interest Group (ASIG)
2015Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysisPatterson, K.; Roberts-Thomson, P.; Lester, S.; Tan, J.; Hakendorf, P.; Rischmueller, M.; Zochling, J.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Nikpour, M.; Stevens, W.; Proudman, S.; Walker, J.
2015Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsWodkowski, M.; Hudson, M.; Proudman, S.; Walker, J.; Stevens, W.; Nikpour, M.; Assassi, S.; Mayes, M.; Tatibouet, S.; Wang, M.; Baron, M.; Fritzler, M.
2017A treat-to-target strategy preserves work capacity in a rheumatoid arthritis inception cohort treated with combination conventional DMARD therapyWechalekar, M.; Quinn, S.; Lester, S.; Metcalf, R.; Shanahan, E.; Walker, J.; Smith, M.; Hill, C.; Shanahan, E.; Proudman, S.
2014Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritisBlack, R.; Spargo, L.; Schultz, C.; Chatterton, B.; Cleland, L.; Lester, S.; Hill, C.; Proudman, S.
2014Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritisWiese, M.; Alotaibi, N.; O'Doherty, C.; Sorich, M.; Suppiah, V.; Cleland, L.; Proudman, S.